Trial intelligence / Profile preview

Prophylactic treatment of episodic cluster headache with candesartan cilexetil

2004-002737-39Phase 4Completed

Sponsor
National Headache Institute
Start
Jan 2005
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in Cluster Headache (CH) comparing candesartan cilexetil with placebo (2 arms). Primary endpoint: Frequency of attacks per week. Started Jan 2005; status: completed.

02

Drugs

candesartan cilexetil
03

Conditions

Cluster Headache (CH)

Beyond the preview

Go deeper on 2004-002737-39.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2004-002737-39.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call